Pidotimod Impurity 13 | CAS 29227-92-7 - Request Quote
Pidotimod Impurity 13
| SZ CAT No: | SZ-P149015 |
| CAS No | 29227-92-7 |
| Mol.F. | C10H14N2O6 |
| Mol.Wt. | 258.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pidotimod Impurity 13 is chemically (5-Oxopyrrolidine-2-carbonyl)-L-glutamic acid. It is also known as Pidolate EP Impurity B. Pidotimod Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Pidotimod Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pidotimod.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 29227-92-7
Purchase 29227-92-7
Order 29227-92-7
Enquire 29227-92-7
price of 29227-92-7
29227-92-7 Supplier
29227-92-7 Manufacturer
29227-92-7 Exporter
buy high quality Pidotimod Impurity 13
Purchase Pidotimod Impurity 13
Pidotimod Impurity 13 suppliers
Pidotimod Impurity 13 manufacturers
Pidotimod Impurity 13 price
Order Pidotimod Impurity 13
Enquire Pidotimod Impurity 13
Pidotimod Impurity 13 cost
Pidotimod Impurity 13 Supplier
Pidotimod Impurity 13 Distributor
Pidotimod Impurity 13 for Method Validation
Pidotimod Reference Standard
Pidotimod Impurity 13 for ANDA Filing
Pidotimod Impurity 13 for Forced Degradation Studies
Pidotimod Impurity 13 Identification Standards
Pidotimod Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


